Short report: Repeat blood culture positive for B. pseudomallei indicates an increased risk of death from melioidosis

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 6, 2011, Pages 858-861

  Limmathurotsakul, Direk ^a   Wuthiekanun, Vanaporn ^a   Wongsuvan, Gumphol ^a   Pangmee, Sukanya ^a   Amornchai, Premjit ^a   Teparrakkul, Prapit ^b   Teerawattanasook, Nittaya ^b   Day, Nicholas P J ^a,c   Peacock, Sharon J ^a,d,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Sappasitthiprasong Hospital   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFTAZIDIME;

ADULT; ARTICLE; BACTEREMIA; BACTERIAL COUNT; BACTERIUM CULTURE; BLOOD CULTURE; BURKHOLDERIA PSEUDOMALLEI; COLONY FORMING UNIT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; MORTALITY; PARENTERAL NUTRITION; PROGNOSIS; PUS; RISK FACTOR; SURVIVAL; THROAT CULTURE; URINALYSIS; ADOLESCENT; BLOOD; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOGENICITY; SPUTUM; STATISTICAL MODEL; SUPPURATION;

BACTERIA (MICROORGANISMS); BURKHOLDERIA PSEUDOMALLEI;

ADOLESCENT; ADULT; BURKHOLDERIA PSEUDOMALLEI; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MELIOIDOSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SPUTUM; SUPPURATION;

EID: 79958740023     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0618     Document Type: Article

References (14)

1. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, Chaowagul W, Day NP, Peacock SJ, 2010. Increasing incidence of human melioidosis in northeast Thailand. Am J Trop Med Hyg 82: 1113-1117.
2. Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, Anstey NM, Mayo MJ, 2000. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop 74: 121-127. (Pubitemid 30069782)
3. Limmathurotsakul D, Wuthiekanun V, Chierakul W, Cheng AC, Maharjan B, Chaowagul W, White NJ, Day NP, Peacock SJ, 2005. Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microbiol 43: 2274-2276. (Pubitemid 40656240)
4. Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ, 1995. Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21: 1498-1500. (Pubitemid 26066650)
5. Walsh AL, Wuthiekanun V, 1996. The laboratory diagnosis of melioidosis. Br J Biomed Sci 53: 249-253. (Pubitemid 27036156)
6. Chaowagul W, Chierakul W, Simpson AJ, Short JM, Stepniewska K, Maharjan B, Rajchanuvong A, Busarawong D, Limmathurotsakul D, Cheng AC, Wuthiekanun V, Newton PN, White NJ, Day NP, Peacock SJ, 2005. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob Agents Chemother 49: 4020-4025. (Pubitemid 41400941)
7. Chaowagul W, Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, White NJ, 1999. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis 29: 375-380. (Pubitemid 29380203)
8. Cheng AC, Limmathurotsakul D, Chierakul W, Getchalarat N, Wuthiekanun V, Stephens DP, Day NP, White NJ, Chaowagul W, Currie BJ, Peacock SJ, 2007. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis 45: 308-314. (Pubitemid 47101026)
9. Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson AJ, Limmathurotsakul D, Cheng AC, Stepniewska K, Newton PN, Chaowagul W, White NJ, Peacock SJ, Day NP, Chetchotisakd P, 2005. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim- sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis 41: 1105-1113. (Pubitemid 41429472)
10. Wuthiekanun V, Limmathurotsakul D, Wongsuvan G, Chierakul W, Teerawattanasook N, Teparrukkul P, Day NP, Peacock SJ, 2007. Quantitation of B. pseudomallei in clinical samples. Am J Trop Med Hyg 77: 812-813.
11. Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ, 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163: 2066-2072. (Pubitemid 37151249)
12. Baughman RP, Kerr MA, 2003. Ventilator-associated pneumonia patients who do not reduce bacteria from the lungs have a worse prognosis. J Intensive Care Med 18: 269-274. (Pubitemid 44544723)
13. Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, Howe PA, Walsh AL, Chaowagul W, White NJ, 1999. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 29: 381-387. (Pubitemid 29380204)
14. Suputtamongkol Y, Rajchanuwong A, Chaowagul W, Dance DA, Smith MD, Wuthiekanun V, Walsh AL, Pukrittayakamee S, White NJ, 1994. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 19: 846-853. (Pubitemid 24368819)